X

Week in review: The latest from PhRMA

Priscilla VanderVeer   |     March 25, 2016   |   SHARE THIS

week-in-review.jpgFDA quality metrics:  Building on our constructive ideas for improvements to the FDA’s recent proposal for a mandatory metrics program, we featured a guest blog post from Mairead Goetz, head of compliance for Novartis in the group quality compliance & audit organization, highlighting potential operability challenges of the program.

Advancing MS treatments – The last decade has changed the reality for patients living with multiple sclerosis (MS).  Previous treatments for the disease were limited to a handful of injected and infused medicines. Today, MS patients have better and more diverse options, such as oral medicines, that carry fewer side effects. Read more about advancements in MS treatments. 

Medicare Monday – This week, we highlighted the Extra Help program within Medicare D by sharing an example from Diane, a hypothetical patient. Twelve million low-income Part D beneficiaries like Diane benefit from the program through cost sharing for their prescriptions and waiving or lowering their premiums and deductibles. Learn why changing this program would harm Medicare beneficiaries.  

Priscilla VanderVeer

Priscilla VanderVeer Priscilla VanderVeer Priscilla VanderVeer is a vice president, public affairs, at PhRMA. Ms. VanderVeer has more than 15 years of experience communicating important health care issues to a wide variety of audiences, including medical, health and patient advocates; policymakers and opinion-leaders; and the general public. At PhRMA, Ms. VanderVeer leads the development and execution of communications strategies and activities for the organization’s key state advocacy priorities. She lives in Annapolis, Maryland with her husband, Ken and their two dogs: Bea Arthur, a tiny 5 lb. Maltese and Henry, a slightly larger-than-average Yorkshire Terrier.

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates